The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Dosage Regimen For Anti-Mif Antibodies - EP3277718

The patent EP3277718 was granted to Baxalta on Mar 24, 2021. The application was originally filed on Mar 31, 2016 under application number EP16712899A. The patent is currently recorded with a legal status of "Revoked".

EP3277718

BAXALTA
Application Number
EP16712899A
Filing Date
Mar 31, 2016
Status
Revoked
Nov 11, 2022
Publication Date
Mar 24, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

SCORPIODec 24, 2021TEUTENADMISSIBLE

Patent Citations (14) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2003235584
DESCRIPTIONUS6645493
DESCRIPTIONWO2009086920
DESCRIPTIONWO2013156473
DESCRIPTIONWO2014086916
INTERNATIONAL-SEARCH-REPORTWO0164749
INTERNATIONAL-SEARCH-REPORTWO02067862
INTERNATIONAL-SEARCH-REPORTWO2013156473
INTERNATIONAL-SEARCH-REPORTWO9817314
OPPOSITIONUS2003099653
OPPOSITIONUS2003235584
OPPOSITIONWO2009086920
OPPOSITIONWO2013156473
OPPOSITIONWO2014086916

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents